Skip to main content

LA DISFUNCION AUTOFAGICA-LISOSOMAL EN LA ENFERMEDAD DE PARKINSON: CARACTERIZACION Y DESARROLLO DE NUEVAS ESTRATEGIAS TRANSLACIONALES CON EL LISOSOMA COMO DIANA TERAPEUTICA.

PI17/00496

•
Funding agency name Instituto de Salud Carlos III
Funding agency acronym ISCIII
Program Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de Investigación en Salud
Call year 2017
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre FUNDACION INSTITUTO DE INVESTIGACION VALLE DE HEBRON
Execution centre INSTITUTO DE INVESTIGACION HOSPITAL UNIVERSITARIO VALLE DE HEBRON (VHIR)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

The Emerging Role of the Lysosome in Parkinson's Disease

  • Navarro-Romero, Alba
  • Montpeyó Garcia-Moreno, Marta|||0000-0002-9241-1047
  • Martinez-Vicente, Marta|||0000-0001-7053-2625
Lysosomal function has a central role in maintaining neuronal homeostasis, and, accordingly, lysosomal dysfunction has been linked to neurodegeneration and particularly to Parkinson's disease (PD). Lysosomes are the converging step where the substrates delivered by autophagy and endocytosis are degraded in order to recycle their primary components to rebuild new macromolecules. Genetic studies have revealed the important link between the lysosomal function and PD; several of the autosomal dominant and recessive genes associated with PD as well as several genetic risk factors encode for lysosomal, autophagic, and endosomal proteins. Mutations in these PD-associated genes can cause lysosomal dysfunction, and since α-synuclein degradation is mostly lysosomal-dependent, among other consequences, lysosomal impairment can affect α-synuclein turnover, contributing to increase its intracellular levels and therefore promoting its accumulation and aggregation. Recent studies have also highlighted the bidirectional link between Parkinson's disease and lysosomal storage diseases (LSD); evidence includes the presence of α-synuclein inclusions in the brain regions of patients with LSD and the identification of several lysosomal genes involved in LSD as genetic risk factors to develop PD
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Lysosomal lipid alterations caused by glucocerebrosidase deficiency promote lysosomal dysfunction, chaperone-mediated-autophagy deficiency, and alpha-synuclein pathology

  • Navarro, Alba|||0000-0002-4041-0974
  • Fernández González, Irene|||0000-0002-4335-6053
  • Riera del Brio, Jordi|||0000-0002-1738-4448
  • Montpeyó Garcia-Moreno, Marta|||0000-0002-9241-1047
  • Albert-Bayo, Mercé|||0000-0002-9726-8083
  • Lopez-Royo, Tresa|||0000-0001-9802-8199
  • Castillo-Sanchez, Pablo
  • Carnicer-Cáceres, Clara
  • Arranz-Amo, Jose Antonio|||0000-0002-2236-4185
  • Castillo-Ribelles, Laura|||0000-0001-9380-7839
  • Pradas-Gracia, Eddie|||0000-0002-3325-7473
  • Casas, Josefina|||0000-0002-7926-5209
  • Vila Bover, Miquel|||0000-0002-1352-989X
  • Martinez-Vicente, Marta|||0000-0001-7053-2625
Mutations in the GBA gene that encodes the lysosomal enzyme β-glucocerebrosidase (GCase) are a major genetic risk factor for Parkinson's disease (PD). In this study, we generated a set of differentiated and stable human dopaminergic cell lines that express the two most prevalent GBA mutations as well as GBA knockout cell lines as a in vitro disease modeling system to study the relationship between mutant GBA and the abnormal accumulation of α-synuclein. We performed a deep analysis of the consequences triggered by the presence of mutant GBA protein and the loss of GCase activity in different cellular compartments, focusing primarily on the lysosomal compartment, and analyzed in detail the lysosomal activity, composition, and integrity. The loss of GCase activity generates extensive lysosomal dysfunction, promoting the loss of activity of other lysosomal enzymes, affecting lysosomal membrane stability, promoting intralysosomal pH changes, and favoring the intralysosomal accumulation of sphingolipids and cholesterol. These local events, occurring only at a subcellular level, lead to an impairment of autophagy pathways, particularly chaperone-mediated autophagy, the main α-synuclein degradative pathway. The findings of this study highlighted the role of lysosomal function and lipid metabolism in PD and allowed us to describe a molecular mechanism to understand how mutations in GBA can contribute to an abnormal accumulation of different α-synuclein neurotoxic species in PD pathology.